Uneven distribution of cancer histology in the national lung screening trial

Thomas A Dillard, Raxit R. Patel, Carsten Schroeder

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The National Lung Screening Trial reported a 20% lower mortality due to lung cancer in the patients screened with low-dose computed tomography (LDCT) compared with plain chest radiography (XRAY). A hypothesis was raised that LDCT should detect more cases of all tissue types or else the distribution of tissue types should be equal between groups. Data were extracted regarding the tissue types of lung cancer and presenting stages from the 2011 NSLT report. A total of 1,993 cases of tissue diagnosed lung cancer were reported, 1,054 for the LDCT group and 939 for the XRAY group. Two tissue types were more prevalent in the XRAY group: small cell carcinomas (16.9% versus 13%; P < 0.05) and other non-small cell (ONSC) carcinomas (16.8% versus 12.4%; P < 0.05). The ONSC category excluded the usual non-small cell tissue types: adenocarcinomas, squamous, and large cell carcinomas and did include other known biologically unfavorable tissue types. The XRAY group also had a disproportionately large number of stage IV small cell and ONSC tumors (P < 0.05 for ONSC). Bronchoalveolar cell carcinomas were more prevalent in the LDCT group (10.4% versus 3.7%, P < 0.05), likely reflecting greater sensitivity for detection. In summary, this review found uneven distribution of cases and higher preponderance of stage IV tumors for 2 adverse tissue types in the XRAY group. The results are consistent with greater severity of disease in the XRAY group with potential for length time bias and reduced mortality benefit from LDCT screening.

Original languageEnglish (US)
Pages (from-to)219-221
Number of pages3
JournalAmerican Journal of the Medical Sciences
Volume350
Issue number3
DOIs
StatePublished - Sep 8 2015

Fingerprint

Histology
Lung
Tomography
Neoplasms
Lung Neoplasms
Carcinoma
Large Cell Carcinoma
Small Cell Carcinoma
Mortality
Tissue Distribution
Radiography
Squamous Cell Carcinoma
Adenocarcinoma
Thorax

Keywords

  • Cancer screening
  • Chest x-ray
  • Low-dose CT scanning
  • Lung cancer

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Uneven distribution of cancer histology in the national lung screening trial. / Dillard, Thomas A; Patel, Raxit R.; Schroeder, Carsten.

In: American Journal of the Medical Sciences, Vol. 350, No. 3, 08.09.2015, p. 219-221.

Research output: Contribution to journalReview article

Dillard, Thomas A ; Patel, Raxit R. ; Schroeder, Carsten. / Uneven distribution of cancer histology in the national lung screening trial. In: American Journal of the Medical Sciences. 2015 ; Vol. 350, No. 3. pp. 219-221.
@article{760217bc7dfe41c3989b7909c5292c92,
title = "Uneven distribution of cancer histology in the national lung screening trial",
abstract = "The National Lung Screening Trial reported a 20{\%} lower mortality due to lung cancer in the patients screened with low-dose computed tomography (LDCT) compared with plain chest radiography (XRAY). A hypothesis was raised that LDCT should detect more cases of all tissue types or else the distribution of tissue types should be equal between groups. Data were extracted regarding the tissue types of lung cancer and presenting stages from the 2011 NSLT report. A total of 1,993 cases of tissue diagnosed lung cancer were reported, 1,054 for the LDCT group and 939 for the XRAY group. Two tissue types were more prevalent in the XRAY group: small cell carcinomas (16.9{\%} versus 13{\%}; P < 0.05) and other non-small cell (ONSC) carcinomas (16.8{\%} versus 12.4{\%}; P < 0.05). The ONSC category excluded the usual non-small cell tissue types: adenocarcinomas, squamous, and large cell carcinomas and did include other known biologically unfavorable tissue types. The XRAY group also had a disproportionately large number of stage IV small cell and ONSC tumors (P < 0.05 for ONSC). Bronchoalveolar cell carcinomas were more prevalent in the LDCT group (10.4{\%} versus 3.7{\%}, P < 0.05), likely reflecting greater sensitivity for detection. In summary, this review found uneven distribution of cases and higher preponderance of stage IV tumors for 2 adverse tissue types in the XRAY group. The results are consistent with greater severity of disease in the XRAY group with potential for length time bias and reduced mortality benefit from LDCT screening.",
keywords = "Cancer screening, Chest x-ray, Low-dose CT scanning, Lung cancer",
author = "Dillard, {Thomas A} and Patel, {Raxit R.} and Carsten Schroeder",
year = "2015",
month = "9",
day = "8",
doi = "10.1097/MAJ.0000000000000516",
language = "English (US)",
volume = "350",
pages = "219--221",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Uneven distribution of cancer histology in the national lung screening trial

AU - Dillard, Thomas A

AU - Patel, Raxit R.

AU - Schroeder, Carsten

PY - 2015/9/8

Y1 - 2015/9/8

N2 - The National Lung Screening Trial reported a 20% lower mortality due to lung cancer in the patients screened with low-dose computed tomography (LDCT) compared with plain chest radiography (XRAY). A hypothesis was raised that LDCT should detect more cases of all tissue types or else the distribution of tissue types should be equal between groups. Data were extracted regarding the tissue types of lung cancer and presenting stages from the 2011 NSLT report. A total of 1,993 cases of tissue diagnosed lung cancer were reported, 1,054 for the LDCT group and 939 for the XRAY group. Two tissue types were more prevalent in the XRAY group: small cell carcinomas (16.9% versus 13%; P < 0.05) and other non-small cell (ONSC) carcinomas (16.8% versus 12.4%; P < 0.05). The ONSC category excluded the usual non-small cell tissue types: adenocarcinomas, squamous, and large cell carcinomas and did include other known biologically unfavorable tissue types. The XRAY group also had a disproportionately large number of stage IV small cell and ONSC tumors (P < 0.05 for ONSC). Bronchoalveolar cell carcinomas were more prevalent in the LDCT group (10.4% versus 3.7%, P < 0.05), likely reflecting greater sensitivity for detection. In summary, this review found uneven distribution of cases and higher preponderance of stage IV tumors for 2 adverse tissue types in the XRAY group. The results are consistent with greater severity of disease in the XRAY group with potential for length time bias and reduced mortality benefit from LDCT screening.

AB - The National Lung Screening Trial reported a 20% lower mortality due to lung cancer in the patients screened with low-dose computed tomography (LDCT) compared with plain chest radiography (XRAY). A hypothesis was raised that LDCT should detect more cases of all tissue types or else the distribution of tissue types should be equal between groups. Data were extracted regarding the tissue types of lung cancer and presenting stages from the 2011 NSLT report. A total of 1,993 cases of tissue diagnosed lung cancer were reported, 1,054 for the LDCT group and 939 for the XRAY group. Two tissue types were more prevalent in the XRAY group: small cell carcinomas (16.9% versus 13%; P < 0.05) and other non-small cell (ONSC) carcinomas (16.8% versus 12.4%; P < 0.05). The ONSC category excluded the usual non-small cell tissue types: adenocarcinomas, squamous, and large cell carcinomas and did include other known biologically unfavorable tissue types. The XRAY group also had a disproportionately large number of stage IV small cell and ONSC tumors (P < 0.05 for ONSC). Bronchoalveolar cell carcinomas were more prevalent in the LDCT group (10.4% versus 3.7%, P < 0.05), likely reflecting greater sensitivity for detection. In summary, this review found uneven distribution of cases and higher preponderance of stage IV tumors for 2 adverse tissue types in the XRAY group. The results are consistent with greater severity of disease in the XRAY group with potential for length time bias and reduced mortality benefit from LDCT screening.

KW - Cancer screening

KW - Chest x-ray

KW - Low-dose CT scanning

KW - Lung cancer

UR - http://www.scopus.com/inward/record.url?scp=84941028171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941028171&partnerID=8YFLogxK

U2 - 10.1097/MAJ.0000000000000516

DO - 10.1097/MAJ.0000000000000516

M3 - Review article

C2 - 26148183

AN - SCOPUS:84941028171

VL - 350

SP - 219

EP - 221

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 3

ER -